What is ProMIS Neurosciences Inc.?
discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 29.60M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 0 | 37,000 shares $116k |
| 9-12months | 0 | 2702,370 shares $8.5M |